Author

R. Vendramelli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 5 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Organism:non-human primate· 1 Organism:rat· 1

Frequent Co-Authors

D. Kobasa· 4 shared K. Tierney· 4 shared N. Tailor· 4 shared D. Safronetz· 3 shared J. Audet· 3 shared L. Garnett· 3 shared M. Chan· 3 shared Y. Deschambault· 3 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

D. Kobasa

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

An S1 subunit vaccine and combination adjuvant (COVAC-1) elicits robust protection against SARS-CoV-2 challenge in African green monkeys

L. Garnett, K. Tran, M. Chan, K. Tierney, Z. Schiffman, J. Audet, J. Lew, C. Meilleur, M. Chan, K. Manguiat, N. Tailor, R. Vendramelli, Y. Deschambault, G. Beaudoin-Bussieres, C. Bourassa, , D. Falzarano

COVAC-1, an S1 subunit vaccine with adjuvant, protects African green monkeys from SARS-CoV-2 challenge by reducing viral load and pathology in the respiratory tract.

bioRxiv · Jun 16, 2022 · PreprintMicrobiology

Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus

Z. Ao, M. Jing Ouyang, T. A. Olukitibi, B. Warner, R. Vendramelli, T. Truong, M. Zhang, S. Kung, K. R. Fowke, D. Kobasa, X. Yao

This study develops and tests a bivalent rVSV vaccine targeting SARS-CoV-2 Delta and influenza, showing strong immune responses and protection in animal models.

bioRxiv · Dec 14, 2021 · PreprintMicrobiology

Single immunization with recombinant ACAM2000 vaccinia viruses expressing the spike and the nucleocapsid proteins protect hamsters against SARS-CoV-2 caused clinical disease

J. Cao, Y. Deschambault, J. Lynch, B. Warner, K. Tierney, D. Huynh, R. Vendramelli, N. Tailor, S. Booth, B. Sajesh, K. Frost, K. LeBlanc, C. Layne, L. Lin, D. Beniac, , D. Kobasa

This study shows that a single immunization with a vaccinia virus expressing both SARS-CoV-2 spike and nucleocapsid proteins protects hamsters better than expressing either protein alone.

bioRxiv · Dec 2, 2021Microbiology

Exposure route, sex, and age influence disease outcome in a golden Syrian hamster model of SARS-CoV-2 infection

B. D. Griffin, B. M. Warner, M. Chan, E. J. Mendoza, N. Tailor, L. Banadyga, A. Leung, S. He, A. S. Boese, J. Audet, W. Cao, E. Moffat, L. Garnett, K. Tierney, K. N. Tran, , D. Kobasa

This study investigates how exposure route, sex, and age affect SARS-CoV-2 pathogenesis in golden Syrian hamsters, finding significant differences in disease outcomes.

bioRxiv · Jun 12, 2021 · PreprintMicrobiology

North American deer mice are susceptible to SARS-CoV-2

B. D. Griffin, M. Chan, N. Tailor, E. J. Mendoza, A. Leung, B. M. Warner, A. T. Duggan, E. Moffat, S. He, L. Garnett, K. N. Tran, L. Banadyga, A. Albietz, K. Tierney, J. Audet, , D. Kobasa

This study shows North American deer mice can be infected and transmit SARS-CoV-2, suggesting they may serve as a potential reservoir for the virus.

bioRxiv · Jul 25, 2020Microbiology